These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8451775)

  • 1. Citalopram: interaction studies with levomepromazine, imipramine, and lithium.
    Gram LF; Hansen MG; Sindrup SH; Brøsen K; Poulsen JH; Aaes-Jørgensen T; Overø KF
    Ther Drug Monit; 1993 Feb; 15(1):18-24. PubMed ID: 8451775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms.
    Sindrup SH; Brøsen K; Hansen MG; Aaes-Jørgensen T; Overø KF; Gram LF
    Ther Drug Monit; 1993 Feb; 15(1):11-7. PubMed ID: 8451774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.
    Skjelbo E; Gram LF; Brøsen K
    Br J Clin Pharmacol; 1993 Mar; 35(3):331-4. PubMed ID: 8471415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence and absolute bioavailability of oblong and coated levomepromazine tablets in CYP2D6 phenotyped subjects.
    Bagli M; Höflich G; Rao ML; Langer M; Baumann P; Kolbinger M; Barlage U; Kasper S; Möller HJ
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):646-52. PubMed ID: 8963481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interaction between imipramine and antidepressant neuroleptics in rats.
    Daniel W
    Pol J Pharmacol Pharm; 1991; 43(3):197-206. PubMed ID: 1683700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphisms--a population study.
    Madsen H; Nielsen KK; Brøsen K
    Br J Clin Pharmacol; 1995 Apr; 39(4):433-9. PubMed ID: 7640151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.
    Brøsen K; Naranjo CA
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):275-83. PubMed ID: 11532381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
    Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans.
    Sidhu J; Priskorn M; Poulsen M; Segonzac A; Grollier G; Larsen F
    Chirality; 1997; 9(7):686-92. PubMed ID: 9366029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.
    Koyama E; Chiba K; Tani M; Ishizaki T
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Citalopram and desmethylcitalopram for psychiatric patients].
    Linnet K; Olesen OV
    Ugeskr Laeger; 1996 Aug; 158(35):4920-3. PubMed ID: 8801700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the route of administration of imipramine on imipramine and desipramine blood levels.
    Rigal J; Albin H; Fança X; Demotes-Mainard F; Vinçon G
    J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of novel atrial-selective antiarrhythmic agent vernakalant hydrochloride injection (RSD1235): influence of CYP2D6 expression and other factors.
    Mao ZL; Wheeler JJ; Clohs L; Beatch GN; Keirns J
    J Clin Pharmacol; 2009 Jan; 49(1):17-29. PubMed ID: 18927241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus.
    Boni J; Abbas R; Leister C; Burns J; Jordan R; Hoffmann M; DeMaio W; Hug B
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):263-70. PubMed ID: 19015855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
    Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.
    Laine K; Tybring G; Härtter S; Andersson K; Svensson JO; Widén J; Bertilsson L
    Clin Pharmacol Ther; 2001 Oct; 70(4):327-35. PubMed ID: 11673748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.
    Aarnoutse RE; Kleinnijenhuis J; Koopmans PP; Touw DJ; Wieling J; Hekster YA; Burger DM
    Clin Pharmacol Ther; 2005 Dec; 78(6):664-74. PubMed ID: 16338282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity.
    Hamelin BA; Bouayad A; Méthot J; Jobin J; Desgagnés P; Poirier P; Allaire J; Dumesnil J; Turgeon J
    Clin Pharmacol Ther; 2000 May; 67(5):466-77. PubMed ID: 10824625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative bioavailability of imipramine (Tofranil) coated tablets in healthy volunteers.
    Ullmann U; Lehnfeld R; Bliesath H; Birkel M; Gebbing H; Gräve M; Wolf H
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):271-6. PubMed ID: 11430636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients.
    de Mendonça Lima CA; Baumann P; Brawand-Amey M; Brogli C; Jacquet S; Cochard N; Powell-Golay K; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):952-6. PubMed ID: 16006029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.